Extended Follow-Up Beyond 2.5 Years Demonstrates Long-Term Efficacy in Complete Responders Following Epcoritamab Monotherapy in Relapsed or Refractory Large B-Cell Lymphoma (R/R LBCL)

被引:0
作者
Karimi, Yasmin H. [1 ]
Thieblemont, Catherine [2 ]
Ghesquieres, Herve [3 ]
Cheah, Chan Y. [4 ,5 ]
Clausen, Michael Roost [6 ]
Cunningham, David [7 ]
Jurczak, Wojciech [8 ]
Linton, Kim M. [9 ,10 ]
Hutchings, Martin [11 ,12 ]
Phillips, Tycel [13 ]
Farooq, Umar [14 ]
Kim, Won Seog [15 ]
Dinh, Minh H. [16 ]
Ghosh, Jagannath [17 ]
Pallai, Rajash [17 ]
Wielgos-Bonvallet, Monica [17 ]
Eskelund, Christian [18 ]
Lugtenburg, Pieternella J. [19 ]
Vose, Julie M. [20 ]
机构
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI USA
[2] Univ Paris, APHP, Hop St Louis, Hematooncol, Paris, France
[3] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Pierre Benite, France
[4] Sir Charles Gairdner Hosp, Nedlands, WA, Australia
[5] Univ Western Australia, Nedlands, WA, Australia
[6] Vejle Hosp, Vejle, Denmark
[7] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England
[8] MSC Natl Res Inst Oncol, Krakow, Poland
[9] Univ Manchester, Christie NHS Fdn Trust, Manchester Canc Res Ctr, Manchester, Lancs, England
[10] Univ Manchester, Div Canc Sci, Manchester, Lancs, England
[11] Rigshosp, Copenhagen, Denmark
[12] Univ Copenhagen, Copenhagen, Denmark
[13] City Hope Natl Med Ctr, Duarte, CA USA
[14] Univ Iowa, Iowa City, IA USA
[15] Samsung Med Ctr, Seoul, South Korea
[16] AbbVie, N Chicago, IL USA
[17] Genmab, Plainsboro, NJ USA
[18] Genmab, Copenhagen, Denmark
[19] Univ Med Ctr, Erasmus MC Canc Inst, Dept Hematol, Rotterdam, Netherlands
[20] Univ Nebraska Med Ctr, Omaha, NE USA
关键词
ALL; bispecific; large B-cell lymphoma; hematologic malignancy; non-Hodgkin lymphoma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ABCL-191
引用
收藏
页码:S461 / S462
页数:2
相关论文
empty
未找到相关数据